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Generation of wheat gluten hydrolysates with dipeptidyl 
peptidase IV (DPP-IV) inhibitory properties 
A. B. Nongonierma
a,b
, M. Hennemann
a
 S. Paolella
a,b
 and R. J. FitzGerald
a,b
* 
Wheat gluten, a Pro-rich dietary protein, was investigated for its potential to produce dipeptidyl peptidase IV (DPP-IV) 
inhibitory peptides during enzymatic hydrolysis with Debitrase HYW20. Nine gluten hydrolysates (H1-H9) were generated 
using a 2 factor  3 level design of experiments (DOE) including the incubation temperature (40, 50 and 60°C) and the 
enzyme: substrate ratio (E:S, 0.5, 1.0 and 1.5% (w/w)). Their DPP-IV half maximal inhibitory concentration (IC50) ranged 
from 0.24  0.02 (H9) to 0.66  0.06 mg mL-1 (H2A and H7) and their degree of hydrolysis (DH) from 31.7  0.9 (H7) to 62.2 
 3.0% (H6). Gluten and H9, the most potent DPP-IV inhibitory hydrolysate, were subjected to simulated gastrointestinal 
digestion (SGID), yielding Gluten_CorPP and H9_CorPP, respectively. H9_CorPP had a higher DPP-IV inhibitory potency 
than Gluten_CorPP (i.e., DPP-IV IC50 values of 0.33  0.03 vs 1.45  0.26 mg mL
-1, respectively). H9 and H9_CorPP both 
contained relatively potent DPP-IV inhibitory peptides such as Val-Pro-Leu, Trp-Leu and Trp-Pro which were identified by 
liquid chromatography tandem mass spectrometry (LC-MS/MS). In addition, several sequences possessing features of DPP-
IV inhibitory peptides, mostly consisting of a penultimate or C-terminal Pro, were identified within H9. The presence of 
Pro-containing peptides within H9 may contribute to its stability to digestive enzymes. Gluten hydrolysates may have 
antidiabetic potential for humans. 
1 Introduction  
Gluten is a group of proteins which is found within several 
cereals, including wheat, rye and barley. Wheat gluten is 
composed of gliadins and glutenins, two major storage 
proteins (prolamins) found in the endosperm, representing up 
to 85% of the total protein content.
1
 Wheat gluten is 
extensively utilised in the bakery industry as it confers 
cohesiveness, viscoelastic and gas retention properties to 
dough.
2
 The viscous properties of wheat gluten have been 
attributed to gliadins while the elastic properties arise from 
the glutenins.
3
 Wheat is a major protein source in the human 
diet. It is estimated to contribute up to 30% of dietary protein 
intake.
2
 However, people suffering from coeliac disease have 
been recommended to follow a strict gluten free-diet.
2
 
Enzymatic hydrolysis of wheat gluten has been proposed to 
reduce its allergenic potential.
4-6
 Interestingly, the process of 
hydrolysis itself may lead to the release of biologically active 
peptides. 
In silico analysis of wheat gluten proteins has revealed that 
they contain several known bioactive peptides having potential 
antioxidant, antihypertensive and antidiabetic properties.
7
 The 
bioactive properties of wheat gluten hydrolysates such as their 
antioxidant and antihypertensive properties have been 
demonstrated in vitro.
8-10
 Numerous dipeptidyl peptidase IV 
(DPP-IV) inhibitory peptides have been identified within wheat 
gliadins and glutenins during in silico studies.
11,12
 DPP-IV is a 
metabolic enzyme which can bring about the degradation and 
inactivation of incretins (e.g., glucagon like peptide-1 (GLP-1) 
and gastric inhibitory polypeptide (GIP)). Incretins have an 
insulinotropic action during the post prandial phase, generally 
resulting in enhanced serum glucose regulation. Inhibition of 
DPP-IV may lead to the restoration of incretin insulinotropic 
action particularly in people suffering from type 2 diabetes 
(T2D).
13
 Therefore, DPP-IV inhibition is therapeutically targeted 
as a means to achieving better serum glucose regulation in 
T2D sufferers. 
Several dietary peptides inhibit DPP-IV in vitro and also in vivo, 
in small animals, for reviews see:
14,15
. Velarde-Salcedo et al.
16
 
showed that an in vitro gastrointestinal digest of wheat flour 
was able to inhibit DPP-IV. To date, limited information is 
available in the literature in relation to the role of wheat 
gluten hydrolysates on DPP-IV inhibition. Wheat gluten 
contains relatively high levels of Pro, Asn, Gln and Arg, but low 
levels of essential amino acids such as Trp, Lys and Met.
1
 Pro 
residues have frequently been reported in peptides having 
DPP-IV inhibitory properties. In particular, peptides with a Pro 
at the penultimate position, which are preferred DPP-IV 
substrates, display substrate-type inhibition of DPP-IV.
17,18
 
Furthermore, several peptides having a Pro at the C-terminus 
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have previously been identified as DPP-IV inhibitors.
19,20
 
Therefore, the utilisation of protein substrates rich in Pro, such 
as wheat gluten, appears to be of interest for the generation 
of DPP-IV inhibitory peptides. 
The aim of this study was to investigate the generation of DPP-
IV inhibitory peptides during enzymatic hydrolysis of wheat 
gluten. This was achieved by hydrolysing wheat gluten with 
Debitrase HWY20, a commercial food-grade enzyme 
preparation. The physicochemical characteristics (degree of 
hydrolysis (DH), peptide profile and molecular mass 
distribution) of the gluten hydrolysates were assessed. The 
stability of the DPP-IV inhibitory properties of the gluten 
hydrolysates following incubation with digestive enzymes was 
studied using an in vitro simulated gastrointestinal digestion 
(SGID) protocol. Peptide identification was subsequently 
carried out by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS). 
Materials and Methods 
Reagents 
2,4,6-Trinitrobenzenesulfonic acid (TNBS) and a bicinchoninic 
acid (BCA) protein assay kit from Pierce Biotechnology were 
purchased from Medical Supply Company (Dublin, Ireland). 
Hydrochloric acid (HCl), sodium hydroxide (NaOH), high 
performance liquid chromatography (HPLC) grade water and 
acetonitrile (ACN) were from VWR (Dublin, Ireland). 
Tris(hydroxymethyl)aminomethane (TRIS), trifluoroacetic acid 
(TFA), sodium phosphate monobasic, sodium phosphate 
dibasic, sodium dodecyl sulphate (SDS), Gly-Pro-pNA, Leu, 
diprotin A (Ile-Pro-Ile), porcine DPP-IV (≥ 10 units mg
-1
 
protein), molecular mass standards (i.e., bovine serum albumin 
(BSA), β-lactoglobulin (β-Lg), -lactalbumin (-La), aprotinin, 
bacitracin, Leu-Trp-Met-Arg and Asp-Glu), wheat gluten, mass 
spectrometry (MS) grade water and ACN were purchased from 
Sigma-Aldrich (Dublin, Ireland). Debitrase HYW20 (11470 U g
-1
) 
was provided by Dupont-Danisco (Marlborough, Wiltshire, UK), 
while pepsin (3000 FCC U g
-1
) was provided by Biocatalysts 
(Cefn, Wales, UK) and Corolase PP (2500 UHb g
-1
), a porcine 
pancreatic enzyme preparation, was supplied by AB Enzymes 
(Darmstadt, Germany). 
Enzymatic hydrolysis of gluten 
The protein content of gluten was determined in triplicate 
(n=3) using the BCA assay as already outlined earlier.
21
 
Gluten was hydrolysed with Debitrase HYW20, using a 2 factor 
 3 level design of experiments (DOE). Each factor was centred 
and reduced (z-centred values). Preliminary experiments 
showed that hydrolysis times < 6 h were not sufficient to fully 
hydrolyse gluten with Debitrase HYW20. In addition, pH (6.0-
8.0) and substrate concentration (2-10% (w/w)) alterations 
were studied. Gluten aggregation occurred at pH > 6.0 and 
concentrations > 2% (w/w). These preliminary experiments 
showed that it was not practical to adjust the pH of the gluten 
suspension to the optimal pH for Debitrase HYW20 (pH 7.0) or 
to study substrate concentrations > 2% (w/w) and hydrolysis 
times < 6 h. Therefore, two hydrolysis factors, i.e., incubation 
temperature (T) and enzyme: substrate ratio (E:S), which did 
not cause gluten to precipitate or induce insufficient gluten 
hydrolysis, were selected. These factors were studied at three 
levels (T, 40(-1), 50(0) and 60(+1)°C and E:S, 0.5(-1), 1(0) and 
1.5(+1)% (w/w)) (Table 1). These levels were chosen to set the 
central point conditions of the DOE (i.e., T 50C and E:S 
1%(w/w)) as described previously for the hydrolysis of bovine 
whey proteins with Debitrase HYW20.
22
 Nine different 
hydrolysates (H1-H9) were generated once with the exception 
of the hydrolysate at the central point conditions generated in 
triplicate (H2, H2B, H2C, n=3). 
Gluten was suspended (2.0% (w protein equivalent/w)) in 
distilled water for 60 min in a water bath (Lauda E100, Lauda 
Brinkmann, Lauda-Königshofen, Germany) set at the hydrolysis 
temperature as defined by the DOE. The pH of the gluten 
suspension was pH 5.6. Debitrase HYW20 was subsequently 
added at the desired E:S ratio as defined in the DOE. Hydrolysis 
was conducted for 24 h
23
 and the enzyme was subsequently 
heat inactivated in a water bath set at 90°C for 20 min. The 
negative control corresponded to unhydrolysed gluten which 
was incubated using the same temperature and time 
conditions as the hydrolysate but without enzyme addition. 
Samples were freeze-dried (FreeZone 18L, Labconco, Kansas 
City, MO, USA) and stored at -20°C prior to analysis. 
In vitro simulated gastrointestinal digestion (SGID) of intact and 
hydrolysed gluten 
Intact gluten and H9 were subjected to SGID in vitro as 
described earlier.
24
 Briefly, samples were resuspended in 
distilled water to 2% (w protein equivalent /w) for 30 min at 
37C and the pH was adjusted to 2.0 using 1 N HCl. Hydrolysis 
with pepsin (E:S 2.5% (w/w)) was carried out under pH 
regulation (2.0) with HCl (pH stat Titrando 843, Tiamo 1.4 
Metrohm, Dublin, Ireland) for 90 min at 37°C. Pepsin was then 
heat inactivated (90°C, 20 min). An aliquot of the peptic 
hydrolysate (H9_pepsin or Gluten_pepsin) was brought to pH 
7.5 using 1 M NaOH and was subsequently hydrolysed with 
Corolase PP (E:S 1% (w/w)) for 150 min at 37°C, pH 7.5 using a 
pH stat (Metrohm), yielding H9_CorPP or Gluten_CorPP. 
Corolase PP contains several intestinal enzyme activities, 
including trypsin, chymotrypsin, elastase and various 
exopeptidases.
25
 The reaction was terminated by thermal 
treatment (90°C, 20 min). Samples were freeze-dried and 
stored at -20°C until utilisation. 
Degree of hydrolysis (DH) 
The DH of the hydrolysates (H1-H9) was determined in 
triplicate (n=3) using the TNBS method as already outlined.
26
 
Absorbance values at 350 nm were measured with a 
microplate reader (Biotek Synergy HT, Winoosky, VT, USA). The 
free amino group concentration (AN) was calculated using a 
Leu standard curve and the absorbance values.
27
 The DH was 
calculated according to Equation 1: 
DH = 100 ×
(AN2−AN1)
N𝑝𝑏 
  Equation 1 
With AN1, the free amino group content of the negative 
control, i.e., unhydrolysed protein (mg g
-1
 protein); AN2, the 
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free amino group content of the hydrolysate (mg g
-1
 protein) 
and Npb, the amino group content of the peptide bonds in the 
protein substrate (112.1 mg g
-1
 protein for wheat gluten)
28
. 
Molecular mass distribution profiling of the hydrolysates using gel 
permeation high performance liquid chromatography (GP-HPLC) 
Gluten hydrolysates were analysed by GP-HPLC as described 
earlier.
29
 A Waters HPLC system (model 600 binary pump, 
model 2707 autosampler and model 2489 dual λ absorbance 
detector interfaced with Empower™, Milford, MA, USA) was 
used for this purpose. Samples were resuspended in the 
mobile phase (0.1% (v/v) TFA and 30% HPLC grade ACN in 
HPLC water) at 0.21% (w protein equivalent/v) and filtered 
through 0.2 µm PTFE syringe filters (VWR). Separation was 
carried out in isocratic mode at 21°C by injecting 20 µL of 
sample into a TSK G2000 SW separating column (600×7.5 mm 
ID - Tosoh Bioscience, Tokyo, Japan) connected to a TSKGEL 
SW guard column (75×7.5 mm ID - Tosoh Bioscience). The flow 
rate was set at 0.5 mL min
-1
 for 60 min. The absorbance was 
monitored at 214 nm. Molecular mass standards (i.e., BSA, β-
Lg, -La, aprotinin, bacitracin, Leu-Trp-Met-Arg and Asp-Glu) 
were used to calibrate the method (Supplementary Fig. S1). 
Four molecular mass bands within the resulting chromatogram 
were defined as > 10, 10-5, 5-1 and < 1 kDa. 
Peptide profiling of the hydrolysates using reverse-phase ultra-
performance liquid chromatography (RP-UPLC) 
The peptide profile of the gluten hydrolysates was determined 
by RP-UPLC (Acquity, Waters) as described earlier.
30
 Solvent A 
was 0.1% (v/v) TFA in MS grade water and solvent B was 0.1% 
(v/v) TFA and 80% MS grade ACN in water. The samples were 
resuspended (0.43% w protein equivalent/v) in solvent A and 
filtered with 0.2 µm cellulose acetate filters (VWR). Separation 
was carried out at 30°C at a flow rate of 0.3 mL min
-1
 using an 
injection volume of 10 µL. An Acquity UPLC BEH C18, 130 Å 
column (2.1 mm  50 mm  1.7 µm) equipped with an Acquity 
BEH C18 (1.7 µm) vanguard pre-column (Waters) were used. 
Peptides and proteins were eluted using a linear gradient: 0-
0.28 min: 100% A; 0.28-60 min: 100-40% A. Absorbance was 
monitored at 214 nm. 
Dipeptidyl peptidase IV (DPP-IV) inhibition assay 
The freeze-dried samples were dispersed in HPLC grade water 
at concentrations ranging from 1.9 × 10
-2
 to 1.9 mg mL
-1
 (final 
concentration expressed in mg protein equivalent mL
-1
). The 
DPP-IV inhibition assay was carried out in triplicate as outlined 
previously.
31
 The DPP-IV half maximal inhibitory concentration 
(IC50) was determined by plotting the percentage inhibition as 
a function of test compound concentration. 
The DPP-IV IC50 values as a function of the E:S and 
temperature were fitted with Matlab (version R2014b, 
MathWorks, Inc, Natick, MA, USA) using a multilinear 
regression (MLR) model (Equation 2).
32
 
𝑌 = 𝛽0 + 𝛽1𝑇 + 𝛽2𝐸𝑆 + 𝛽3𝑇
2+𝛽4𝐸𝑆
2 + 𝛽5𝑇 × 𝐸𝑆 + 𝜀 
Equation 2 
With Y, the DPP-IV IC50 value; 0 to 5, the coefficients of the 
model and ε, the residual of the model. 
 
 
Table 1. Degree of hydrolysis (DH) and dipeptidyl peptidase IV (DPP-IV) half maximal inhibitory concentration (IC50) of gluten hydrolysates generated within the design of 
experiments (DOE, H1-H9), H9 digested with pepsin (H9_pepsin), H9_pepsin digested with Corolase PP (H9_CorPP), gluten digested with pepsin (Gluten_pepsin) and 
Gluten_pepsin digested with Corolase PP (Gluten_CorPP). 
Hydrolysate Variable levels1 DH2,3 (%) DPP-IV IC50
2,4 
(mg mL-1) Temperature (°C) E:S (%) 
H1 50 (0) 0.5 (-1) 37.9 ± 1.5 0.53 ± 0.05 
H2A 50 (0) 1.0 (0) 59.5 ± 2.5 0.66 ± 0.06 
H2B 50 (0) 1.0 (0) 61.6 ± 2.5 0.43 ± 0.04 
H2C 50 (0) 1.0 (0) 57.9 ±2.5 0.42 ± 0.04 
H3 50 (0) 1.5 (+1) 58.8 ± 0.8 0.37 ± 0.04 
H4 40 (-1) 0.5 (-1) 40.0 ± 2.2 0.48 ± 0.02 
H5 40 (-1) 1.0 (0) 60.6 ± 1.0 0.34 ± 0.04 
H6 40 (-1) 1.5 (+1) 62.2 ± 3.0 0.35 ± 0.03 
H7 60 (+1) 0.5 (-1) 31.7 ± 0.9 0.66 ± 0.06 
H8 60 (+1) 1.0 (0) 39.1 ± 2.0 0.46 ± 0.06 
H9 60 (+1) 1.5 (+1) 55.5 ± 4.6 0.24 ± 0.02 
H9_pepsin - - nd 0.40 ± 0.03 
H9_CorPP - - nd 0.33 ± 0.03 
Gluten_pepsin - - nd > 1.90 
Gluten_CorPP - - nd 1.45 ± 0.26 
1The z-centred values for each variable of the experimental design are provided in brackets. 
2Mean  SD (n=3). 
3nd: not determined. The SD of the DH for the triplicate determination of H2A, H2B and H2C was 1.9%. 
4IC50: concentration inducing 50% DPP-IV inhibition, expressed in mg protein equivalent per mL (mg mL
-1). The SD of the DPP-IV IC50 value for the H2A, H2B and H2C 
was 0.13 mg mL-1. The IC50 value of the positive control Ile-Pro-Ile was 4.02 ± 0.51 µM. 
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Liquid chromatography tandem mass spectrometric (LC-MS/MS) 
analyses of the hydrolysates 
Peptide identification in H9 and H9_CorPP was carried out by 
LC-MS/MS using an Acquity UPLC (Waters) fitted with an 
Acquity BEH C18, 130 Å column (2.1 mm  50 mm  1.7 µm). 
The UPLC was coupled to a quadrupole time-of-flight mass 
spectrometer (Q-TOF, Impact HD™, Bruker Daltonics GmbH, 
Bremen, Germany) using a 50-600 and 50-2500 m/z acquisition 
range as described earlier.
33
 The MS was fitted with an 
electrospray ionization (ESI) source used in positive ion mode. 
Data acquisition was performed with Hystar software (Bruker 
Daltonics). 
Samples were resuspended in mobile phase A (0.1% formic 
acid in MS water) to a final concentration of 0.1 mg mL
-1
. A 
sample volume of 2 µL was injected in the UPLC. Peptide 
identification was carried with PEAKS Studio (version 7.5, 
Bioinformatics Solutions Inc, Waterloo, Canada). The false 
discovery rate (FDR) and the average local confidence (ALC) 
were set at 1 and 60%, respectively. 
Previously identified DPP-IV inhibitory peptides for which an 
IC50 value was available in the literature as well as peptides 
displaying features of known DPP-IV inhibitory peptides, i.e., 
hydrophobic amino acid (Trp (W1), Leu (L1), Ile (I1) or Phe (F1)) 
at the N-terminus and/or a Pro (P2)/Ala (A2) at position 2 
and/or Pro at the C-terminus (P-term) of the peptide,
11,19,34
 
were searched for within H9 and H9_CorPP. 
Statistical analysis 
A one-way analysis of variance (ANOVA) at a significance level 
p < 0.05 was used to study the significance of the coefficient of 
the MLR (Equation 2) with Matlab. The DH and DPP-IV IC50 
values of the triplicate determination of H2 was studied using 
an ANOVA which was followed by a Student Newman-Keuls 
test for multiple means comparison (p < 0.05) using SPSS 
(version 22, SPSS Inc., Chicago, IL, USA). 
Results 
DPP-IV inhibitory properties of the gluten hydrolysates 
Gluten controls were not able to inhibit DPP-IV (IC50 > 1.9 mg 
mL
-1
). In contrast, all hydrolysates (H1-H9) generated within 
the DOE displayed DPP-IV inhibitory properties. Their DPP-IV 
IC50 ranged from 0.24  0.02 (H9) to 0.66  0.06 mg mL
-1
 (H2A 
and H7, Table 1). Hydrolysate generation was reproducible 
from a DPP-IV inhibition point of view for H2B and H2C (p > 
0.05, Table 1). Significant differences were seen between H2A 
and H2B/H2C (p < 0.05). However, all these three hydrolysates 
had DPP-IV IC50 values of the same order. These differences 
may come from the fact that gluten is poorly soluble in water, 
which may have resulted in some variation in the peptides 
released during the hydrolysis process. 
While statistical treatment indicated that hydrolysis 
temperature had a significant effect on the DPP-IV IC50 value (p 
< 0.05, Table 2), the MLR model was not statistically significant 
(p > 0.05, Table 2). 
Physicochemical properties of the gluten hydrolysates 
The protein content of the starting gluten preparation was 
determined to be 61.71 ± 0.66% (w/w). Gluten was hydrolysed 
to different extents depending on the hydrolysis conditions 
employed. The DH of the nine hydrolysates generated within 
the DOE varied between 31.7  0.9 (H7) and 62.2  3.0% (H6, 
Table 1). The DH of the three hydrolysates (H2A, H2B and H2C) 
made in the central point conditions were not significantly 
different (p > 0.05, Table 1). 
Intact gluten contained mostly proteins having a molecular 
mass > 10 kDa, which accounted for > 95% of the sample (Fig. 
1). Following hydrolysis, proteins were extensively degraded as 
can be seen in the hydrolysates (H1-H9), which contained < 
10% material > 10 kDa (Fig. 1). Enzymatic digestion of gluten 
resulted in the generation of low molecular mass components, 
with the material < 1 kDa representing > 50% of the 
hydrolysates. H2A, H2B and H2C displayed similar molecular 
mass distribution profiles (Fig. 1). 
SGID of gluten and H9 
Following digestion with pepsin (Gluten_pepsin), the DPP-IV 
inhibitory properties of gluten were not modified (DPP-IV IC50 
> 1.90 mg mL
-1
, Table 1). However, further digestion with 
Corolase PP (Gluten_CorPP) induced a decrease in DPP-IV IC50 
value to 1.45  0.26 mg mL
-1
 (Table 1). The digestion of H9 
with pepsin (H9_pepsin) and pepsin and Corolase PP 
(H9_CorPP) led to an increase in the DPP-IV IC50 value (0.40  
0.03 and 0.33  0.03 mg mL
-1
, respectively, Table 1). 
The molecular mass distribution profile of the SGID samples is 
illustrated on Fig. 1. In Gluten_pepsin, proteins (> 10 kDa) 
were degraded into smaller molecular mass components (< 10 
kDa). Proteins were further degraded in Gluten_CorPP. 
However, both Gluten_pepsin and Gluten_CorPP still 
contained significant amounts of proteins (> 17% material > 10 
kDa). There was a decrease in the proportion of proteins (> 10 
kDa) in H9_pepsin. There were no intact proteins remaining in 
H9_CorPP, which only contained material < 5 kDa (Fig. 1). 
Along with differences in molecular mass distribution profiles, 
H9, H9_pepsin and H9_CorPP displayed different peptide 
profiles (Supplementary Fig. S2), suggesting that certain 
sequences within H9 were not stable to digestive enzymes. 
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Table 2. Coefficients of the multilinear regression (MLR) model (Equation 2) correlating the dipeptidyl peptidase IV (DPP-IV) half maximal inhibitory concentration (IC50) of the 
gluten hydrolysates to the parameters of the design of experiments (DOE) and their interactions. 
Parameters 
of the model1 
Estimate value of 
the coefficients 
Standard Error t value p 
Intercept 0.48 0.05 9.73 1.95E-04 
T -0.12 0.04 -3.00 0.03 
ES 0.03 0.04 0.79 0.46 
T² -0.01 0.06 -0.12 0.91 
ES2 -0.06 0.06 -0.95 0.38 
TES -0.07 0.05 -1.46 0.21 
Root mean squared error: 0.097; R2: 0.719; p-value model = 0.163 
1T: temperature and ES: enzyme to substrate ratio. 
2Coefficients of the parameters having a p < 0.05 are significantly different from 0 
Peptides identified within H9 and H9_CorPP 
Numerous peptide sequences were identified by LC-MS/MS 
within H9 and H9_CorPP. Those peptides within both samples 
for which a DPP-IV IC50 value had previously been reported in 
the literature are listed in Table 2. These consisted of di- and 
tripeptides. Approximately 95% of the DPP-IV inhibitory 
peptides reported in Table 2 were common between H9 and 
H9_CorPP. H9 and H9_CorPP contained relatively potent DPP-
IV inhibitory peptides such as, Trp-Leu and Trp-Pro. Val-Pro-
Leu, a potent DPP-IV inhibitor known as Diprotin B, was also 
found in H9 and H9_CorPP. 
Several peptides identified within H9 had the features of DPP-
IV inhibitory peptides. Peptides with DPP-IV inhibitory 
features, which were identified in /-gliadin (accession 
number P18573), one of the major gluten protein, are listed in 
Table 3. While several sequences have been identified for their 
ability to inhibit DPP-IV in vitro, their DPP-IV IC50 value has not 
as yet been evaluated. Two main features were seen among 
these peptides, i.e., having a Pro in the penultimate or C-
terminal positions (~ 80% of the peptides, Table 3). Several 
peptides with an N-terminal Phe or Leu were also present. One 
peptide with an Ala at the penultimate position was detected 
while no peptides containing Ile or Trp N-terminal residues 
were identified. 
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Figure 1. Molecular mass distribution profiles of the gluten hydrolysates generated within the design of experiments (DOE, H1-H9), H9 digested with pepsin (H9_pepsin), 
H9_pepsin digested with Corolase PP (H9_CorPP), gluten digested with pepsin (Gluten_pepsin) and Gluten_pepsin digested with Corolase PP (Gluten_CorPP).
Table 3. Half maximal inhibitory concentration (IC50) values of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides identified within H9 and H9 digested with pepsin and then 
Corolase PP (H9_CorPP). 
Peptide sequence1 Identified in DPP-IV IC50 value (µM)2 References 
H9 H9_CorPP 
AL   882 31 
AP   7950 20 
FL   400 31 
FP   3630 ; 683 20,35 
HP   2820 ; 903 20,35 
L(I)A   91 ; 88 ;300 36,37 
LL   192 38 
LP   713 ; 2370 17,20 
LPL   241 17 
LPP   563 35 
LQP   1181 19 
MP   870 20 
PP   5860 ; 4344 20,39 
RP   1240 ; 657 20,35 
SL   2517 31 
SP   5980 20 
TP   2370 20 
VP   880 ; 381 ;93 ; 785 20,35,36,39 
VPL   16 40 
VR   826 31 
WL   44 41 
WP   4530 ; 45 20,41 
YL   940 42 
YP   3170 ; 658 ; 7564 17,20,39 
1Peptide sequences abbreviated with the one letter amino acid code. Each peptide sequence could be found within several individual wheat proteins. 
2DPP-IV IC50 : dipeptidyl peptidase IV half maximal inhibitory concentration. 
 
Discussion 
Several studies have shown that cereal proteins constitute 
good starting substrates for the generation of bioactive 
peptides.
43,44
 Gluten, the major protein group in wheat, is a 
rich source of Pro. Pro residues appear to play a key role in 
DPP-IV inhibition when they are located in the penultimate or 
the C-terminal positions of peptides. In addition, in silico 
studies have indicated that wheat gluten contains numerous 
DPP-IV inhibitory peptide motifs.
11,12
 Therefore, gluten was 
evaluated for its ability to serve as a substrate for the 
enzymatic generation of DPP-IV inhibitory peptides. The DPP-
IV inhibitory properties of barley, buckwheat and oat glutenin 
hydrolysates have been studied.
45,46
 To our knowledge, there 
is only one previous publication which reported on the DPP-IV 
inhibitory properties of wheat flour.
16
 
The highest DPP-IV inhibitory potency was observed with H9 
(DPP-IV IC50 = 0.24  0.02 mg mL
-1
, Table 1). This value is lower 
than those generally found with other cereal protein 
hydrolysates. DPP-IV IC50 values ranging from 1.83 to 8.15 mg 
mL
-1
 for tryptic hydrolysates of barley, buckwheat and oat 
proteins have been reported.
45
 Alcalase, Flavourzyme and 
Corolase PP barley protein hydrolysates had DPP-IV IC50 values 
between 2.45 and 3.57 mg mL
-1
.
38
 However, an oat glutenin 
Alcalase hydrolysate with a DPP-IV IC50 value (0.13 mg mL
-1
) of 
the same order as H9 has been described.
45
 The DPP-IV 
inhibitory potency of H9 was ~ 2.5 times higher than that of 
relatively potent milk
31
 and plant (quinoa,
21
 hemp, pea, rice 
and soy)
47
 protein hydrolysates evaluated using the same 
experimental protocol. 
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Table 4. Peptides identified within H9, which originate from wheat /-gliadin (accession number P18573) and which possess the features of dipeptidyl peptidase IV (DPP-IV) 
inhibitory peptides. 
Peptide sequence1 Fragment 
number2 
DPP-IV inhibitory peptide features3 In vitro DPP-IV 
inhibition4 
References4 
W1 I1 L1 F1 P2 A2 P-term 
AP (f279-280)        
20,36
FE (f253-254)         36 
FP diverse         20,35 
FPG (f30-32)          
FPGQQQPFPPQQPYPQPQP (f30-48)          
FPGQQQPFPPQQPYPQPQPFP (f30-50)          
FPGQQQPFPPQQPYPQPQPFPSQQPY (f30-55)          
FPPQQPYP (f37-44)          
FPPQQPYPQPQPFP (f37-50)          
FPPQQPYPQPQPFPSQQPY (f37-55)          
FPQ (f61-63)          
FQ (f218-219), 
(f232-233) 
        36 
FQP (f232-234)          
L(I)A (f259-260)         36,37 
LAL (f259-261)          
LE (f261-262)         36 
LH (f198-199)         36 
L(I)P diverse         17,20,36 
LPYP diverse          
LPYPQPQLPYPQP (f66-78), 
(f73-85) 
         
LPYPQPQLPYPQPQLPYPQPQP (f66-87)          
LQ diverse          
LQP (f8-10), 
(f58-60) 
        19 
L(I)S (f213-214)         36 
L(I)SQ (f213-215)          
NP (f12-13), 
(f238-239) 
        36 
NPQ (f238-240)          
NPS (f12-14)          
NPSQQQPQEQVP (f12-23)          
PP (f38-39), 
(f273-274) 
        20,36,39 
PQP diverse          
QFP (f29-31)          
QLP diverse          
QLPYPQPQLPYPQPQP (f72-87)          
QLPYPQPQP (f79-87)          
QP diverse         36 
QPFP diverse          
QPFPPQQPYPQPQPFP (f35-50)          
QPFPPQQPYPQPQPFPSQQP (f35-54)          
QPFPPQQPYPQPQPFPSQQPY (f35-55)          
QPL(I) (f211-213)          
QPQ diverse          
QPQP diverse          
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QPY diverse          
QQFP (f28-31)          
QQP diverse          
QQQPFPPQQPYPQPQP (f33-48)          
QQQPFPPQQPYPQPQPFP (f33-50)          
QQQPFPPQQPYPQPQPFPSQQP (f33-54)          
QYP (f224-226)          
RP (f89-90)         20,35,36 
TLP (f263-265)          
VP diverse         20,35,36,39 
VPL (f22-24)         40 
VPQ (f5-7)          
VPV (f3-5)          
VPVP (f3-6)          
VPVPQLQPQNPS (f3-14)          
VPVPQLQPQNPSQQQPQ (f3-19)          
VPVPQLQPQNPSQQQPQEQVP (f3-23)          
VPVPQLQPQNPSQQQPQEQVPL (f3-24)          
VPVPQLQPQNPSQQQPQEQVPLVQ (f3-26)          
YP diverse         17,20,36,39 
YPQ diverse          
YPS (f225-227)          
YPSG (f225-228)          
1Peptides sequences abbreviated with the one letter amino acid code. 
2diverse: peptide sequence found at more than two locations within wheat /-gliadin. Fragment numbers are provided for the mature protein sequence. 
3 Trp (W1), Leu (L1), Ile (I1) or Phe (F1) at the N-terminus of the peptide; Pro (P2) or Ala (A2) at position 2 of the peptide; Pro at the C-terminus (P-term) of the peptide. 
4Peptides which have been identified as DPP-IV inhibitors in the literature. 
DPP-IV inhibitory peptides are generally relatively short (< 10 
amino acids), for review, see:
14
. This is in agreement with the 
fact that hydrolysates displaying the largest proportion of 
material < 1 kDa (e.g., H3, H5, H6 and H9) were also generally 
the most potent DPP-IV inhibitory hydrolysates (Table 1). The 
DPP-IV inhibitory potency of H9 decreased to a small extent 
following SGID (0.24  0.02 vs. 0.33  0.03 mg mL
-1
, for H9 and 
H9_CorPP, respectively, Table 1). The DPP-IV IC50 value of 
Gluten_CorPP (1.45  0.26 mg mL
-1
, Table 1) was higher than 
that of the SGID of wheat flour (0.8 mg mL
-1
)
16
 but of the same 
order as that of the SGID of barley, buckwheat or oat flour 
(0.99-3.91 mg mL
-1
)
45
. The higher DPP-IV inhibitory potency of 
H9_CorPP compared to Gluten_CorPP suggests that it may be 
beneficial to prehydrolyse gluten prior to ingestion. 
Several known DPP-IV inhibitory peptides were identified 
within H9 and H9_CorPP (Table 2 and 3), most of which were 
short ( 3 amino acids). Three relatively potent peptides, Val-
Pro-Leu, Trp-Leu and Trp-Pro, having DPP-IV IC50 values < 50 
µM,
40,41
 were found both in H9 and H9_CorPP (Table 2). While 
these peptides may, in part, be responsible for the DPP-IV 
inhibitory potency of the hydrolysates, other peptides may 
also play a role in the overall bioactivity. Peptides with a 
penultimate Pro have been shown to behave as substrate-type 
DPP-IV inhibitors.
17,18
 In addition, the presence of Pro at the C-
terminal position also appears to be a good predictor for DPP-
IV inhibition activity of peptides.
19,20
 Interestingly, a large 
proportion (~ 80 %) of the peptides originating from /-
gliadin, which were identified within H9, contained either a 
penultimate or C-terminal Pro (Table 3). 
Debitrase HYW20, does not appear to have been used for the 
generation of DPP-IV inhibitory food protein hydrolysates, for 
review, see: Lacroix and Li-Chan.
14
 Debitrase HYW20 is an 
enzyme preparation derived from Aspergillus niger, with an 
unknown cleavage specificity. It has been reported to contain 
both endo- and exoprotease activities,
22
 which may explain the 
relatively high DH values observed in the hydrolysates (Table 
1). Similar DH values up to 43
48
 or 64%
49
 have been reported 
for wheat gluten hydrolysates obtained with Flavourzyme and 
Alcalase, respectively, which are two enzyme preparations also 
having broad cleavage specificity. 
The presence of these Pro-containing peptides possessing DPP-
IV inhibitory features within H9 is partly explained by the 
particularly high Pro content of gluten. In addition, it is likely 
that the enzyme activities within Debitrase HYW20 also played 
a role in DPP-IV inhibitory peptide release. The relatively minor 
reduction of the DPP-IV IC50 value of H9 following SGID 
(H9_CorPP) may arise from the fact that Pro-containing 
peptides have been reported to be relatively stable to 
digestive enzymes.
50
 
Future work may include bioassay-driven fractionation of H9, 
confirmatory studies with synthetic peptides and 
quantification of DPP-IV inhibitory peptides. The study of their 
technofunctional and additional other bioactive properties of 
the wheat gluten hydrolysates is also of interest. Wheat gluten 
hydrolysates have been shown to possess a range of 
technofunctionalities.
49,51
 Furthermore, in the context of 
coeliac disease, the degradation of gluten epitopes through 
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the enzymatic hydrolysis used herein is also worthy of further 
investigation.
48,52,53
 
Conclusions 
Gluten can be used as a protein substrate for the enzymatic 
generation of DPP-IV inhibitory hydrolysates. H9, a relatively 
potent DPP-IV inhibitory hydrolysate was produced on 
incubation (60C for 24 h) of gluten with Debitrase HYW20 at 
an E:S of 1.5%. This hydrolysate contained short (di- and tri-) 
peptides previously identified as DPP-IV inhibitors. In addition, 
several peptides possessing DPP-IV inhibitory features, mostly 
comprising of Pro residues at the penultimate and C-terminal 
positions, were identified within H9. These may play a role in 
the overall DPP-IV inhibitory properties of H9. Interestingly, 
the DPP-IV inhibition activity of H9 was minimally reduced 
following SGID. In addition, the higher DPP-IV inhibitory 
potency of H9_CorPP compared to that of Gluten_CorPP, 
suggests the possibility of a more efficient release of DPP-IV 
inhibitory peptides on prehydrolysis of gluten prior to 
ingestion. In vivo evaluation of the gluten hydrolysates is 
required in order to study their antidiabetic potential. 
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Supplementary data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S1. Calibration curve for the gel permeation high performance liquid chromatography (GP-HPLC) method representing the retention time (RT) 
as a function of the logarithm of the molecular weight (MW) of the standards (i.e., bovine serum albumin, β -Lactoglobulin, -Lactalbumin, aprotinin, bacitracin, Leu-
Trp-Met-Arg and Asp-Glu). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2. Reverse-phase ultra-performance liquid chromatography (RP-UPLC) profile of H9, H9 digested with pepsin (H9_pepsin) and H9_pepsin 
digested with Corolase PP (H9_CorPP). ACN: acetonitrile. 
 
